"Pacific Research Partners (@PacificTrials) is a clinical research center located in Oakland, CA and is an extension of the Apex group of clinical research centers. Pacific Trials conducts a wide variety of mental, neurological, and general health phase 2-4 clinical research studies."

During the past decade, Pacific Research Partners, LLC conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 42 clinical trials were completed, i.e. on average, 93.3% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 27 clinical trials were completed. i.e. 192.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pacific Research Partners, LLC" #1 sponsor was "Pfizer" with 6 trials, followed by "Eli Lilly and Company" with 5 trials sponsored, "Biohaven Pharmaceuticals, Inc." with 4 trials sponsored, "Indivior Inc." with 4 trials sponsored and "Naurex, Inc, an affiliate of Allergan plc" with 4 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pacific Research Partners, LLC" #1 collaborator was "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "H. Lundbeck A/S" with 2 trials as a collaborator, "Cognitive Research Corporation" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Insulet Corporation" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Pacific Research Partners, LLC" are "Schizophrenia" (14 trials), "Major Depressive Disorder" (8 trials), "Depressive Disorder, Major" (5 trials), "Adjunctive Treatment of Major Depressive Disorder" (3 trials) and "Binge Eating Disorder" (2 trials). Many other conditions were trialed in "Pacific Research Partners, LLC" in a lesser frequency.

Most popular intervention types in "Pacific Research Partners, LLC" are "Drug" (55 trials), "Other" (3 trials), "Combination Product" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (29 trials), "Brexpiprazole" (3 trials), "Pimavanserin" (3 trials), "Rapastinel" (3 trials) and "Rimegepant" (3 trials). Other intervention names were less common.

The vast majority of trials in "Pacific Research Partners, LLC" are 57 trials for "All" genders.

Currently, there are NaN active trials in "Pacific Research Partners, LLC". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 46 completed trials in Pacific Research Partners, LLC, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Pacific Research Partners, LLC, 0 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 1 trials that are defined as “Not Applicable".